Fred Alger Management Inc. reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 68.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 144,515 shares of the medical research company’s stock after selling 308,788 shares during the quarter. Fred Alger Management Inc.’s holdings in Thermo Fisher Scientific were worth $27,441,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in TMO. Longview Partners Guernsey LTD boosted its stake in shares of Thermo Fisher Scientific by 6.8% in the fourth quarter. Longview Partners Guernsey LTD now owns 4,876,890 shares of the medical research company’s stock valued at $926,024,000 after buying an additional 311,977 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Thermo Fisher Scientific by 4.2% in the fourth quarter. Geode Capital Management LLC now owns 3,917,221 shares of the medical research company’s stock valued at $742,108,000 after buying an additional 158,961 shares in the last quarter. Veritas Asset Management LLP boosted its stake in shares of Thermo Fisher Scientific by 44.1% in the third quarter. Veritas Asset Management LLP now owns 3,503,259 shares of the medical research company’s stock valued at $662,817,000 after buying an additional 1,072,500 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of Thermo Fisher Scientific by 2.8% in the fourth quarter. Wells Fargo & Company MN now owns 3,189,088 shares of the medical research company’s stock valued at $605,543,000 after buying an additional 85,751 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in shares of Thermo Fisher Scientific by 3.7% in the third quarter. Ameriprise Financial Inc. now owns 2,545,362 shares of the medical research company’s stock valued at $481,554,000 after buying an additional 90,393 shares in the last quarter. Institutional investors own 86.79% of the company’s stock.
In other news, SVP Gregory J. Herrema sold 33,327 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $219.70, for a total value of $7,321,941.90. Following the completion of the transaction, the senior vice president now directly owns 60,471 shares of the company’s stock, valued at $13,285,478.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Stephen Williamson sold 2,500 shares of the business’s stock in a transaction on Monday, March 5th. The stock was sold at an average price of $204.60, for a total value of $511,500.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 98,827 shares of company stock worth $20,193,272. 0.49% of the stock is owned by company insiders.
Shares of Thermo Fisher Scientific Inc. (TMO) opened at $217.89 on Friday. The company has a current ratio of 1.34, a quick ratio of 0.92 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $85,057.69, a price-to-earnings ratio of 38.91, a price-to-earnings-growth ratio of 1.55 and a beta of 1.15. Thermo Fisher Scientific Inc. has a 12-month low of $151.74 and a 12-month high of $226.44.
Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, topping the Zacks’ consensus estimate of $2.66 by $0.13. The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $5.72 billion. Thermo Fisher Scientific had a return on equity of 16.01% and a net margin of 10.64%. Thermo Fisher Scientific’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.41 earnings per share. equities analysts predict that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.31%. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. The ex-dividend date is Wednesday, March 14th. Thermo Fisher Scientific’s payout ratio is presently 10.71%.
TRADEMARK VIOLATION NOTICE: This piece was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3253735/fred-alger-management-inc-has-27-44-million-holdings-in-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.